Cytodyn Inc (CYDY)

[mercurio]

Ridiculous statement. Both of their trials failed. We don't even know how badly the trials actually failed because they are only showing us a few cherrypicked parts.

The critical patients had 24% efficacy. If 2 placebo patients had lived instead of dying, theirwould have been more mortality in the leronlimab arm of critical patients.

The trials were poorly designed because CYDY's management is incompetent. The drug works but Nader and Kelly are terrible managers.

Also, my children knew the difference between "there", "they're", and "their" when they were in elementary school. If you want to be taken seriously, I'd suggest you learn the difference.